Literature DB >> 27150364

Heterocyclic Naphthalimides as New Skeleton Structure of Compounds with Increasingly Expanding Relational Medicinal Applications.

Huo-Hui Gong, Dinesh Addla, Jing-Song Lv, Cheng-He Zhou1.   

Abstract

Naphthalimide compounds are an important type of nitrogen-containing aromatic heterocycles with cyclic double imides and the naphthalene framework. This π-deficient large conjugated planar structure enables naphthalimide derivatives to readily interact with various biological cations, anions, small molecules and macromolecules such as DNAs, enzymes and recetors in living organism via noncovalent bonds, therefore exhibiting extensive potentiality in relatively medicinal applications. Currently, some naphthalimides as anticancer agents have entered into clinical trials and other naphthalimide-based medicinal developments as potential drugs for treatment of various diseases are actively and unprecedentedly expanding. Naphthalimide-derived artificial ion receptors, fluorescent probes and cell imaging agents are being overwhelmingly investigated and have a diversity of potential applications in real-time detecting ions and biomolecules, understanding biological processes and determining pharmacological and pharmacokinetic properties. All the above mentions have strongly implied that naphthalimide-based derivatives as new skeleton structure of compounds possess increasingly expanding relational medicinal applications, and the related research is becoming a quite attractive active topic and newly rising highlight. Combining with our research and referring other works from literature, this work systematically reviews the current research and development of heterocyclic naphthalimides as anticancer, antibacterial, antifungal, antiviral, anti-inflammatory, antidepressant agents as well as artificial cation and anion receptors, diagnostic agents and pathologic probes, and cell imaging agents for biologically important species. Some rational design strategies, structure-activity relationships and action mechanisms are discussed. The perspectives of the future development of naphthalimide-based medicinal chemistry are also presented.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27150364     DOI: 10.2174/1568026616666160506145943

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  9 in total

1.  Functionalized Naphthalimide-4-aminoquinoline Conjugates as Promising Antiplasmodials, with Mechanistic Insights.

Authors:  Jenny Legac; Adebayo A Adeniyi; Prishani Kisten; Philip J Rosenthal; Parvesh Singh; Vipan Kumar
Journal:  ACS Med Chem Lett       Date:  2020-01-08       Impact factor: 4.345

2.  Novel Naphthalimide Aminothiazoles as Potential Multitargeting Antimicrobial Agents.

Authors:  Ying-Ying Chen; Lavanya Gopala; Rammohan R Yadav Bheemanaboina; Han-Bo Liu; Yu Cheng; Rong-Xia Geng; Cheng-He Zhou
Journal:  ACS Med Chem Lett       Date:  2017-12-01       Impact factor: 4.345

3.  Design, synthesis and biological evaluation of novel Schiff base-bridged tetrahydroprotoberberine triazoles as a new type of potential antimicrobial agents.

Authors:  Jun-Rong Duan; Han-Bo Liu; Ponmani Jeyakkumar; Lavanya Gopala; Shuo Li; Rong-Xia Geng; Cheng-He Zhou
Journal:  Medchemcomm       Date:  2017-02-16       Impact factor: 3.597

4.  Discovery of potential antifungal triazoles: design, synthesis, biological evaluation, and preliminary antifungal mechanism exploration.

Authors:  Yuan Zhang; Guri L V Damu; Sheng-Feng Cui; Jia-Li Mi; Vijai Kumar Reddy Tangadanchu; Cheng-He Zhou
Journal:  Medchemcomm       Date:  2017-06-15       Impact factor: 3.597

5.  Novel N-(Substituted) Thioacetamide Quinazolinone Benzenesulfonamides as Antimicrobial Agents.

Authors:  Mostafa M Ghorab; Ali S Alqahtani; Aiten M Soliman; Ahmed A Askar
Journal:  Int J Nanomedicine       Date:  2020-05-05

6.  A novel triazolonaphthalimide induces apoptosis and inhibits tumor growth by targeting DNA and DNA-associated processes.

Authors:  Liyan Ji; Simin Yang; Shasha Li; Shan Liu; Shunan Tang; Zhongqiu Liu; Xiangbao Meng; Siwang Yu
Journal:  Oncotarget       Date:  2017-06-06

7.  Novel sulphonamide-bearing methoxyquinazolinone derivatives as anticancer and apoptosis inducers: synthesis, biological evaluation and in silico studies.

Authors:  Ali S Alqahtani; Mostafa M Ghorab; Fahd A Nasr; Mohammad Z Ahmed; Abdullah A Al-Mishari; Sabry M Attia
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

8.  The Antiproliferative and Apoptotic Effects of a Novel Quinazoline Carrying Substituted-Sulfonamides: In Vitro and Molecular Docking Study.

Authors:  Ali S Alqahtani; Mostafa M Ghorab; Fahd A Nasr; Mohammad Z Ahmed; Abdullah A Al-Mishari; Sabry M Attia
Journal:  Molecules       Date:  2022-02-01       Impact factor: 4.411

9.  Synthesis and in vitro anti-proliferative evaluation of naphthalimide-chalcone/pyrazoline conjugates as potential SERMs with computational validation.

Authors:  Sourav Taru Saha; Mandeep Kaur; Ebenezer Oluwakemi; Paul Awolade; Parvesh Singh; Vipan Kumar
Journal:  RSC Adv       Date:  2020-04-21       Impact factor: 4.036

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.